Stockscreener 앱 받기
470.21
1.19%
5.52
시간 외 거래:
470.21
Thermo Fisher Scientific Inc (TMO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-12-31 | 2025-09-27 | 2025-06-28 | 2025-03-29 | 2024-12-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
9.83%
12,215.00
|
11,122.00 | 10,855.00 | 10,364.00 | 11,395.00 |
Operating Expenses
|
8.48%
9,960.00
|
9,181.00 | 9,021.00 | 8,648.00 | 9,379.00 |
| Benefits Costs and Expenses |
8.24%
10,062.00
|
9,296.00 | 9,146.00 | 8,744.00 | 9,454.00 |
| Costs And Expenses |
8.47%
9,960.00
|
9,182.00 | 9,021.00 | 8,648.00 | 9,379.00 |
| Operating Income/Loss |
16.18%
2,255.00
|
1,941.00 | 1,834.00 | 1,716.00 | 2,016.00 |
| Income/Loss Before Equity Method Investments |
17.91%
2,153.00
|
1,826.00 | 1,709.00 | 1,620.00 | 1,941.00 |
| Income/Loss From Equity Method Investments |
1,700%
-32.00
|
2.00 | 2.00 | -14.00 | 33.00 |
| Income/Loss From Continuing Operations Before Tax |
17.91%
2,153.00
|
1,826.00 | 1,709.00 | 1,620.00 | 1,941.00 |
| Income Tax Expense/Benefit, Deferred |
170.08%
89.00
|
-127.00 | - | - | - |
| Income Tax Expense/Benefit |
26.09%
153.00
|
207.00 | 92.00 | 95.00 | 150.00 |
| Income/Loss From Continuing Operations After Tax |
23.53%
2,000.00
|
1,619.00 | 1,617.00 | 1,525.00 | 1,791.00 |
|
Net Income/Loss
|
21.53%
1,970.00
|
1,621.00 | 1,618.00 | 1,511.00 | 1,824.00 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
20.00%
6.00
|
5.00 | 2.00 | 4.00 | -6.00 |
| Basic Average Shares |
100.26%
-1.00
|
378.00 | 378.00 | 378.00 | - |
| Diluted Average Shares |
100.00%
-
|
378.00 | 378.00 | 379.00 | - |
| Basic Earnings Per Share |
21.96%
5.22
|
4.28 | 4.28 | 3.99 | 4.79 |
| Diluted Earnings Per Share |
22.01%
5.21
|
4.27 | 4.28 | 3.98 | 4.78 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.73%
0.47%
자본화:
|
볼륨(24시간):